Umbert P, Belcher R W, Winkelmann R K
Br J Dermatol. 1976 Nov;95(5):481-5. doi: 10.1111/j.1365-2133.1976.tb00857.x.
Serum MIF activity was studied in ten patients with sarcoidosis, fourteen with granuloma annulare, four with necrobiosis lipoidica, and nine with various dermatological diseases. Positive MIF activity was found in the sera of nine of the ten patients with sarcoidosis and eleven of the fourteen patients with granuloma annulare. The delayed hypersensitivity tests were negative in all nine of the patients with sarcoidosis who had serum MIF activity and were positive in only three patients with cutaneous sarcoid lesions. One of four patients with necrobiosis lipoidica demonstrated minimal serum MIF activity. Data on serum lymphokine activity in sarcoidosis and granuloma annulare suggest that these two diseases are related to delayed hypersensitivity mechanisms.
对10例结节病患者、14例环状肉芽肿患者、4例类脂质渐进性坏死患者和9例患有各种皮肤病的患者的血清巨噬细胞移动抑制因子(MIF)活性进行了研究。在10例结节病患者中的9例血清以及14例环状肉芽肿患者中的11例血清中发现了阳性MIF活性。在所有9例具有血清MIF活性的结节病患者中,迟发型超敏反应试验均为阴性,而在仅有3例皮肤结节病病变患者中呈阳性。4例类脂质渐进性坏死患者中有1例表现出最低限度的血清MIF活性。结节病和环状肉芽肿血清淋巴因子活性的数据表明,这两种疾病与迟发型超敏反应机制有关。